Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 203

1.

Effect of Glyceryl Trinitrate on Hemodynamics in Acute Stroke.

Appleton JP, Woodhouse LJ, Bereczki D, Berge E, Christensen HK, Collins R, Gommans J, Ntaios G, Ozturk S, Szatmari S, Wardlaw JM, Sprigg N, Rothwell PM, Bath PM; ENOS Investigators * .

Stroke. 2019 Jan 10:STROKEAHA118023190. doi: 10.1161/STROKEAHA.118.023190. [Epub ahead of print]

PMID:
30626285
2.

Blood pressure variability in hypertensive patients with atrial fibrillation in the VALUE trial.

Mehlum MH, Liestøl K, Wyller TB, Hua TA, Rostrup M, Berge E.

Blood Press. 2019 Jan 6:1-7. doi: 10.1080/08037051.2018.1524707. [Epub ahead of print]

PMID:
30614275
3.

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

Sawhney JP, Kothiwale VA, Bisne V, Durgaprasad R, Jadhav P, Chopda M, Vanajakshamma V, Meena R, Vijayaraghavan G, Chawla K, Allu J, Pieper KS, John Camm A, Kakkar AK; GARFIELD-AF Investigators.

Indian Heart J. 2018 Nov - Dec;70(6):828-835. doi: 10.1016/j.ihj.2018.09.001. Epub 2018 Sep 12.

4.

Change in Cardiorespiratory Fitness and Risk of Stroke and Death.

Prestgaard E, Mariampillai J, Engeseth K, Erikssen J, Bodegård J, Liestøl K, Gjesdal K, Kjeldsen S, Grundvold I, Berge E.

Stroke. 2018 Dec 10:STROKEAHA118021798. doi: 10.1161/STROKEAHA.118.021798. [Epub ahead of print]

PMID:
30580727
5.

Quantitative Label-Free Imaging of 3D Vascular Networks Self-Assembled in Synthetic Hydrogels.

Kaushik G, Gil DA, Torr E, Berge ES, Soref C, Uhl P, Fontana G, Antosiewicz-Bourget J, Edington C, Schwartz MP, Griffith LG, Thomson JA, Skala MC, Daly WT, Murphy WL.

Adv Healthc Mater. 2018 Dec 19:e1801186. doi: 10.1002/adhm.201801186. [Epub ahead of print]

PMID:
30565891
6.

Central masked adjudication of stroke diagnosis at trial entry offered no advantage over diagnosis by local clinicians: Secondary analysis and simulation.

Godolphin PJ, Hepburn T, Sprigg N, Walker L, Berge E, Collins R, Gommans J, Ntaios G, Pocock S, Prasad K, Wardlaw JM, Bath PM, Montgomery AA.

Contemp Clin Trials Commun. 2018 Nov 10;12:176-181. doi: 10.1016/j.conctc.2018.11.002. eCollection 2018 Dec. Review.

7.

Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials.

Salam A, Atkins E, Sundström J, Hirakawa Y, Ettehad D, Emdin C, Neal B, Woodward M, Chalmers J, Berge E, Yusuf S, Rahimi K, Rodgers A; Blood Pressure Lowering Treatment Trialists’ Collaboration.

J Hypertens. 2019 Jan;37(1):16-23. doi: 10.1097/HJH.0000000000001994.

PMID:
30499920
8.

Response to letters from Torp-Pedersen and colleagues and de Courson and colleagues.

Mehlum MH, Liestøl K, Kjeldsen SE, Berge E.

Eur Heart J. 2018 Dec 14;39(47):4221. doi: 10.1093/eurheartj/ehy605. No abstract available.

PMID:
30496492
9.

Central adjudication of serious adverse events did not affect trial's safety results: Data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial.

Godolphin PJ, Montgomery AA, Woodhouse LJ, Bereczki D, Berge E, Collins R, Díez-Tejedor E, Gommans J, Lees KR, Ozturk S, Phillips S, Pocock S, Prasad K, Szatmari S, Wang Y, Bath PM, Sprigg N; ENOS Investigators.

PLoS One. 2018 Nov 26;13(11):e0208142. doi: 10.1371/journal.pone.0208142. eCollection 2018.

10.

Percutaneous vascular interventions versus intravenous thrombolytic treatment for acute ischaemic stroke.

Lindekleiv H, Berge E, Bruins Slot KM, Wardlaw JM.

Cochrane Database Syst Rev. 2018 Oct 26;10:CD009292. doi: 10.1002/14651858.CD009292.pub2. Review.

PMID:
30365156
11.

SBP above 180 mmHg at moderate exercise workload increases coronary heart disease risk in healthy men during 28-year follow-up.

Mariampillai JE, Prestgaard EE, Kjeldsen SE, Liestøl K, Engeseth K, Erikssen J, Bodegard J, Berge E, Grundvold I, Skretteberg PT.

J Hypertens. 2018 Oct 12. doi: 10.1097/HJH.0000000000001959. [Epub ahead of print]

PMID:
30325341
12.

Systematic review of organizational models for intra-arterial treatment of acute ischemic stroke.

Ciccone A, Berge E, Fischer U.

Int J Stroke. 2018 Oct 10:1747493018806157. doi: 10.1177/1747493018806157. [Epub ahead of print]

PMID:
30303811
13.

NIHSS cut point for predicting outcome in supra- vs infratentorial acute ischemic stroke.

Yoshimura S, Lindley RI, Carcel C, Sato S, Delcourt C, Wang X, Chalmers J, Anderson CS; ENCHANTED Investigators.

Neurology. 2018 Oct 30;91(18):e1695-e1701. doi: 10.1212/WNL.0000000000006437. Epub 2018 Sep 28.

PMID:
30266885
14.

PRECIOUS: PREvention of Complications to Improve OUtcome in elderly patients with acute Stroke. Rationale and design of a randomised, open, phase III, clinical trial with blinded outcome assessment.

Reinink H, de Jonge JC, Bath PM, van de Beek D, Berge E, Borregaard S, Ciccone A, Csiba L, Demotes J, Dippel DW, Kõrv J, Kurkowska-Jastrzebska I, Lees KR, Macleod MR, Ntaios G, Randall G, Thomalla G, van der Worp HB.

Eur Stroke J. 2018 Sep;3(3):291-298. doi: 10.1177/2396987318772687. Epub 2018 Apr 30.

15.

Impact of hydration status on haemodynamics, effects of acute blood pressure-lowering treatment, and prognosis after stroke.

Billington CK, Appleton JP, Berge E, Sprigg N, Glover M, Bath PMW.

Br J Clin Pharmacol. 2018 Dec;84(12):2914-2922. doi: 10.1111/bcp.13761. Epub 2018 Oct 10.

16.

A randomized controlled trial to test efficacy and safety of thrombectomy in stroke with extended lesion and extended time window.

Bendszus M, Bonekamp S, Berge E, Boutitie F, Brouwer P, Gizewski E, Krajina A, Pierot L, Randall G, Simonsen CZ, Zeleňák K, Fiehler J, Thomalla G.

Int J Stroke. 2018 Aug 29:1747493018798558. doi: 10.1177/1747493018798558. [Epub ahead of print]

PMID:
30156479
17.

Recanalisation therapies for wake-up stroke.

Roaldsen MB, Lindekleiv H, Mathiesen EB, Berge E.

Cochrane Database Syst Rev. 2018 Aug 21;8:CD010995. doi: 10.1002/14651858.CD010995.pub2.

PMID:
30129656
18.

Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials.

Coutts SB, Berge E, Campbell BC, Muir KW, Parsons MW.

Int J Stroke. 2018 Dec;13(9):885-892. doi: 10.1177/1747493018790024. Epub 2018 Jul 23.

PMID:
30035698
19.

Protocol for a prospective collaborative systematic review and meta-analysis of individual patient data from randomized controlled trials of vasoactive drugs in acute stroke: The Blood pressure in Acute Stroke Collaboration, stage-3.

Sandset EC, Sanossian N, Woodhouse LJ, Anderson C, Berge E, Lees KR, Potter JF, Robinson TG, Sprigg N, Wardlaw JM, Bath PM; Blood pressure in Acute Stroke Collaboration Investigators.

Int J Stroke. 2018 Oct;13(7):759-765. doi: 10.1177/1747493018772733. Epub 2018 May 3.

PMID:
29720045
20.

Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data.

Karmali KN, Lloyd-Jones DM, van der Leeuw J, Goff DC Jr, Yusuf S, Zanchetti A, Glasziou P, Jackson R, Woodward M, Rodgers A, Neal BC, Berge E, Teo K, Davis BR, Chalmers J, Pepine C, Rahimi K, Sundström J; Blood Pressure Lowering Treatment Trialists’ Collaboration.

PLoS Med. 2018 Mar 20;15(3):e1002538. doi: 10.1371/journal.pmed.1002538. eCollection 2018 Mar.

Supplemental Content

Loading ...
Support Center